Acer has announced two new Helios Neo brand laptops with AI enabling features, including an Intel Core Ultra 9 275HX and the ...

Donald Trump's return to The White House as president earlier this week also saw the comeback of the iconic Coca-Cola button. President Trump's Oval Office return is hardly 48 hours old, but the 47th ...

President Donald Trump has been sworn back into the White House, and with him returns the classic soda button. The valet button, which the president used to order Diet Coke beverages between 2017 ...

It is the largest study ever of the drug category—which includes Novo Nordisk’s GLP-1 treatments Ozempic and Wegovy and Eli Lilly’s dual-action GLP-1/GIP agonists Mounjaro and Zepbound.

The revamped White House Oval Office will once again feature the Diet Coke button that President Trump used to summon sodas during his first term. The famous little red button, hidden inside a ...

Luxury fashion house LVMH has reclaimed its title as Europe’s most valuable company from Novo Nordisk, as early signs of a luxury comeback coincided with fresh struggles for the Danish Ozempic ...

Bernard Arnault is once again in charge of Europe's most valuable company. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...

The Acer Nitro Blaze 11 is an interesting gaming handheld, which does prove that bigger can be better in some ways. The screen is gorgeous and the versatility of its detachable controllers makes ...

Novo Nordisk has commenced the STEP UP and STEP UP T2D trials to explore the efficacy of semaglutide 7.2mg. Credit: © 2025 Novo Nordisk A/S. Novo Nordisk’s high ...

Bagsværd, Denmark, 17 January 2025 – Novo Nordisk today announced headline results from STEP UP, a phase 3b trial in the global STEP programme. STEP UP is a 72-week efficacy and safety trial ...

Accept its older hardware and distinctly average display, and the Acer Aspire 7 can easily earn its keep as an all-rounder family laptop – including some gaming on the side. The Acer Aspire 7 is the ...

With nearly $14 billion in sales in 2023, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo Nordisk A/S (NYSE: NVO). A Scandinavian economic behemoth ...